Matthew Ros
Overview
Matthew Ros received an average of $2M in total compensation, including $386K in salary, at Epizyme from 2016 to 2020.
Source: SEC filings on April 29, 2021, April 17, 2020, April 18, 2019, and April 5, 2018.
Related executives
We found 13 more executives who work or worked at Epizyme.
Robert Bazemore
Epizyme
Chief Executive Officer
Jeffery Kutok
Epizyme
Chief Scientific Officer
Shefali Agarwal
Epizyme
Executive Vice President, Chief Medical and Development Officer
Paolo Tombesi
Epizyme
Chief Financial Officer
Suzanne Fleming
Epizyme
Former Senior Vice President, Finance and Treasurer
Susan Graf
Epizyme
Former Chief Business Officer
Peter Ho
Epizyme
Chief Medical Officer
Robert Bazemore
Epizyme